Recognizing the physician, not the institution
Institutions commonly receive a “Center of Excellence” distinction based on their ability to provide a wide range of approved radioligand therapies. But given how many radioligand therapies are still under investigation — and the unique expertise it takes to conduct these complex trials — TheranosticTrials developed an exclusive distinction recognizing the physician investigator as an individual who has demonstrated vast experience across a wide range of investigational radioligand therapies and imaging.